Our state of-the-art cGMP process produces innovative robust applications that deliver high quality, scalable, stable, and viable custom formulations. The USSF quality control process provides consistent performance through each stage of the manufacturing processes, meeting rigid quality standards and ensuring products are manufactured and labeled properly.
Vaccine development consists of cutting-edge equipment for vaccine adjuvant development and other cGMP materials for use in vaccine manufacturing. In addition to manufacturing capability, USSF has dedicated teams for cell line development, process development, analytical development, quality control and assurance, program management, and regulation. Our stringent quality system ensures all cGMP requirements are met to manufacture and release clinical products.
Innovative extraction methods and the latest production equipment are used to produce botanical extracts. Our cGMP compliant production facility has the proper methods, equipment, facilities, and controls to produce botanical extracts at a consistently high level of quality.
The manufacture of small molecule products combines our process chemistry expertise with analytical solutions tailored to your specific program. Our small molecule products provide active pharmaceutical ingredient (API) and drug substance development services with pharmaceutical and biotechnology applications for complex, niche, and small molecule programs from preclinical to Phase III and commercial manufacturing.
